These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 350580)

  • 1. The binding of kirromycin to elongation factor Tu. Structural alterations are responsible for the inhibitory action.
    Pingoud A; Urbanke C; Wolf H; Maass G
    Eur J Biochem; 1978 May; 86(1):153-7. PubMed ID: 350580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP.
    Pingoud A; Block W; Wittinghofer A; Wolf H; Fischer E
    J Biol Chem; 1982 Oct; 257(19):11261-7. PubMed ID: 6749837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
    Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
    Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nucleotide- and aurodox-induced changes in elongation factor Tu conformation upon its interactions with aminoacyl transfer RNA. A fluorescence study.
    Dell VA; Miller DL; Johnson AE
    Biochemistry; 1990 Feb; 29(7):1757-63. PubMed ID: 2110000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA.
    Wolf H; Assmann D; Fischer E
    Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5324-8. PubMed ID: 364475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The elongation factor Tu.kirromycin complex has two binding sites for tRNA molecules.
    van Noort JM; Duisterwinkel FJ; Jonák J; Sedlácek J; Kraal B; Bosch L
    EMBO J; 1982; 1(10):1199-205. PubMed ID: 6765192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the reactivity of the GTP- and GDP-bound conformations of elongation factor Tu in complex with the antibiotic GE2270 A.
    Anborgh PH; Parmeggiani A
    J Biol Chem; 1993 Nov; 268(33):24622-8. PubMed ID: 8227020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
    Fasano O; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
    Anborgh PH; Okamura S; Parmeggiani A
    Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the elongation factors from calf brain. 2. Functional properties of EF-1 alpha, the action of physiological ligands and kirromycin.
    Crechet JB; Parmeggiani A
    Eur J Biochem; 1986 Dec; 161(3):647-53. PubMed ID: 3641717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli.
    Pingoud A; Block W; Urbanke C; Wolf H
    Eur J Biochem; 1982 Apr; 123(2):261-5. PubMed ID: 6122571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrophotometric and kinetic studies on the interaction of antibiotic X5108, the N-methylated derivative of kirromycin, with elongation factor Tu from Escherichia coli.
    Eccleston JF
    J Biol Chem; 1981 Apr; 256(7):3175-7. PubMed ID: 6782099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence characterization of the interaction of various transfer RNA species with elongation factor Tu.GTP: evidence for a new functional role for elongation factor Tu in protein biosynthesis.
    Janiak F; Dell VA; Abrahamson JK; Watson BS; Miller DL; Johnson AE
    Biochemistry; 1990 May; 29(18):4268-77. PubMed ID: 2190631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of Val20 by Gly in elongation factor Tu. Effects on the interaction with elongation factors Ts, aminoacyl-tRNA and ribosomes.
    Jacquet E; Parmeggiani A
    Eur J Biochem; 1989 Nov; 185(2):341-6. PubMed ID: 2684669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between aminoacyl-tRNA and the mutant elongation factors Tu AR and B0.
    Abrahams JP; Acampo JJ; Ott G; Sprinzl M; de Graaf JM; Talens A; Kraal B
    Biochim Biophys Acta; 1990 Aug; 1050(1-3):226-9. PubMed ID: 2207147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
    Navratil T; Spremulli LL
    Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antibiotics, N-acetylaminoacyl-tRNA and other agents on the elongation-factor-Tu dependent and ribosome-dependent GTP hydrolysis promoted by 2'(3')-O-L-phenylalanyladenosine.
    Campuzano S; Modolell J
    Eur J Biochem; 1981 Jun; 117(1):27-31. PubMed ID: 6114863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglena gracilis chloroplast elongation factor Tu. Interaction with guanine nucleotides and aminoacyl-tRNA.
    Sreedharan SP; Spremulli LL
    J Biol Chem; 1985 Jul; 260(15):8771-6. PubMed ID: 3926760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding. Crystal structure of the complex between EF-Tu.GDP and aurodox.
    Vogeley L; Palm GJ; Mesters JR; Hilgenfeld R
    J Biol Chem; 2001 May; 276(20):17149-55. PubMed ID: 11278992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.